Percutaneous comprehensive cryoablation for metastatic hepatocellular cancer

Cryobiology

Volumn 66, Issue 1, 2013, Pages 76-80

  Mu, Feng ^a   Niu, Lizhi ^b,c   Li, Haibo ^a   Liao, Mengtian ^a   Li, Li ^a   Liu, Chunyan ^a   Chen, Jibing ^a,b   Li, Jialiang ^b,c   Zuo, Jiansheng ^a,b   Xu, Kecheng ^a,b  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^c Fuda Institute of Cryosurgery for Cancer   (China)

Author keywords

Cryosurgery; Metastatic hepatocellular cancer; Transarterial chemoembolization

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; HEMOSTATIC AGENT;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ASCITES; BLOOD TRANSFUSION; BONE METASTASIS; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPREHENSIVE CRYOABLATION; CONTROLLED STUDY; CRYOABLATION; CRYOSURGERY; FEMALE; HEPATORRHAGIA; HUMAN; LIVER ABSCESS; LIVER CANCER; LIVER TUMOR; LUNG METASTASIS; MALE; METASTASIS POTENTIAL; MULTIPLE ORGAN FAILURE; OVERALL SURVIVAL; PATIENT SAFETY; PERIOPERATIVE PERIOD; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL TIME; THERAPY EFFECT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT DURATION;

ADULT; AGED; CHEMOEMBOLIZATION, THERAPEUTIC; CRYOSURGERY; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84873523574     PISSN: 00112240     EISSN: 10902392     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2012.11.008     Document Type: Article

References (26)

1. Azizi A., Naguib N.N., Mbalisike E., Farshid P., Emami A.H., Vogl T.J. Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival. Pancreas 2011, 40:1271-1275.
2. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
3. Burroughs A., Hochhauser D., Meyer T. Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. Lancet Oncol. 2004, 5:409-418.
4. Chun J.M., Kwon H.J., Sohn J., Kim S.G., Park J.Y., Bae H.I., Yun Y.K., Hwang Y.J. Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma. J. Surg. Oncol. 2011, 103:148-151.
5. Davis C.R. Interventional radiological treatment of hepatocellular carcinoma. Cancer Control 2010, 17:87-99.
6. Dusheiko G.M., Hobbs K.E., Dick R., Burroughs A.K. Treatment of small hepatocellular carcinomas. Lancet 1992, 340:285-288.
7. Eisenhauer E.A., Therasse P., Bogaerts J., Schwartz L.H., Sargent D., Ford R., Dancey J., Arbuck S., Gwyther S., Mooney M., Rubinstein L., Shankar L., Dodd L., Kaplan R., Lacombe D., Verweij J. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 2009, 45:228-247.
8. Fuss M., Salter B.J., Herman T.S., Thomas C.R. External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy. Gastroenterology 2004, 127:S206-S217.
9. Gage A.A., Baust J.M., Baust J.G. Experimental cryosurgery investigations in vivo. Cryobiology 2009, 59:229-243.
10. Gasparini D., Sponza M., Marzio A., Zanardi R., Bazzocchi M., Cemal Y. Combined treatment, TACE and RF ablation, in HCC: preliminary results. Radiol. Med. 2002, 104:412-420.
11. Goldberg S.N., Grassi C.J., Cardella J.F., Charboneau J.W., Dodd G.D., Dupuy D.E., Gervais D., Gillams A.R., Kane R.A., Lee F.T., Livraghi T., McGahan J., Phillips D.A., Rhim H., Silverman S.G. Image-guided tumor ablation: standardization of terminology and reporting criteria. J. Vasc. Interv. Radiol. 2005, 16:765-778.
12. Hodgson H.J. Primary hepatocellular carcinoma. Br. J. Hosp. Med. 1983, 29:240. (246, 250 passim).
13. Johnson P.J. Hepatocellular carcinoma: is current therapy really altering outcome?. Gut 2002, 51:459-462.
14. Liao G.S., Yu C.Y., Shih M.L., Chan D.C., Liu Y.C., Yu J.C., Chen T.W., Hsieh C.B. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma. Eur. J. Surg. Oncol. 2008, 34:61-66.
15. Liaw Y.F., Lin D.Y. Transcatheter hepatic arterial embolization in the treatment of hepatocellular carcinoma. Hepatogastroenterology 1990, 37:484-488.
16. Llovet J.M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J.F., de Oliveira A.C., Santoro A., Raoul J.L., Forner A., Schwartz M., Porta C., Zeuzem S., Bolondi L., Greten T.F., Galle P.R., Seitz J.F., Borbath I., Haussinger D., Giannaris T., Shan M., Moscovici M., Voliotis D., Bruix J. Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med. 2008, 359:378-390.
17. Okuda K., Ohtsuki T., Obata H., Tomimatsu M., Okazaki N., Hasegawa H., Nakajima Y., Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985, 56:918-928.
18. Orlacchio A., Bazzocchi G., Pastorelli D., Bolacchi F., Angelico M., Almerighi C., Masala S., Simonetti G. Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience. Cardiovasc. Intervent. Radiol. 2008, 31:587-594.
19. Paul S.B., Gamanagatti S.R., Aneesh M.K., Acharya S.K. Percutaneous ablative therapy for hepatocellular carcinoma. Natl Med. J. India 2011, 24:347-355.
20. Pearson A.S., Izzo F., Fleming R.Y., Ellis L.M., Delrio P., Roh M.S., Granchi J., Curley S.A. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am. J. Surg. 1999, 178:592-599.
21. Pistorius G.A., Alexander C., Krisch C.M., Feifel G., Schilling M.K., Menger M.D. Local platelet trapping as the cause of thrombocytopenia after hepatic cryotherapy. World J. Surg. 2005, 29:657-660. (discussion 661).
22. Said A., Wells J. Management of hepatocellular carcinoma. Minerva Med. 2009, 100:51-68.
23. Seifert J.K., Morris D.L. World survey on the complications of hepatic and prostate cryotherapy. World J. Surg. 1999, 23:109-113. (discussion 113-104).
24. Shibata T., Isoda H., Hirokawa Y., Arizono S., Shimada K., Togashi K. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?. Radiology 2009, 252:905-913.
25. Shimizu T., Sakuhara Y., Abo D., Hasegawa Y., Kodama Y., Endo H., Shirato H., Miyasaka K. Outcome of MR-guided percutaneous cryoablation for hepatocellular carcinoma. J. Hepatobiliary Pancreat. Surg. 2009, 16:816-823.
26. Xu K.C., Niu L.Z., Zhou Q., Hu Y.Z., Guo D.H., Liu Z.P., Lan B., Mu F., Li Y.F., Zuo J.S. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. World J. Gastroenterol. 2009, 15:3664-3669.